The China biologics market is poised for substantial growth, with forecasts indicating a remarkable surge in market size from USD 39.76 billion in 2023 to USD 278.42 billion by 2035. This represents an impressive compound annual growth rate (CAGR) of 17.73% over the forecast period. With increasing demand for personalized medicine and advancements in biotechnology, the momentum within this...

The India biologics market is charting an impressive course, projected to reach a staggering USD 166.91 billion by 2035, propelled by a compound annual growth rate (CAGR) of 16.888%. The market, valued at USD 30.81 billion in 2024, is on a trajectory that highlights the country's commitment to advancing affordable healthcare solutions. Innovations in biologics, particularly in monoclonal...

The Biologics Market is poised for substantial transformation, with projections indicating a remarkable leap from USD 358.3 billion in 2024 to a staggering USD 3,338.29 billion by 2035. This impressive forecast is underpinned by a compound annual growth rate (CAGR) of 4.54%. The demand for biologics, characterized by their effectiveness in treating complex diseases, is surging, driven by an...